Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Nature|May 4, 2022
Landscape of helper and regulatory antitumour CD4+ T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in GlioblastomaJ Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.Nature Medicine|January 22, 2021
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanomaZhuting Hu, Donna E Leet, Rosa L Allesøe, et al.Cancer Cell|September 24, 2019
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid MalignanciesRomain Guièze, Vivian M Liu, Daniel Rosebrock, et al.The Journal of Clinical Investigation|July 1, 2022
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinomaPatrick C Lee, Susan Klaeger, Phuong M Le, et al.Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.Nature|April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomasMehdi Touat, Yvonne Y Li, Adam N Boynton, et al.Pageof 8